Table 4.
Multivariate predictors of plasma B-type natriuretic peptide (BNP) and amino-terminal pro-B-type natriuretic peptide (NT-proBNP)
| B | SE | 95% CI | β | P | |
|---|---|---|---|---|---|
| BNP | |||||
| LV mass/BSA | 0.012 | 0.004 | 0.005 to 0.019 | 0.258 | 0.0016 |
| β-blocker usage | 0.489 | 0.179 | 0.135 to 0.843 | 0.219 | 0.0071 |
| NT-proBNP | |||||
| GFR | −0.035 | 0.006 | −0.046 to −0.023 | −0.426 | <0.00001 |
| β-blocker usage | 0.527 | 0.157 | 0.217 to 0.837 | 0.235 | 0.0010 |
| LV mass/BSA | 0.008 | 0.003 | 0.002 to 0.015 | 0.179 | 0.011 |
| hemoglobin | −0.086 | 0.038 | −0.161 to −0.012 | −0.165 | 0.023 |
B, unstandardized regression coefficient; β, standardized regression coefficient; CI, confidence intervals; SE, standard error of the estimate; LV, left ventricular; BSA, body surface area; GFR, glomerular filtration rate.